MMW — System, Test, Tumor Marker, Monitoring, Bladder Class II

FDA Device Classification

FDA product code MMW covers "System, Test, Tumor Marker, Monitoring, Bladder", a Class II medical device regulated under 21 CFR 866.6010. Submissions are reviewed by the Immunology panel. At least 9 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
MMW
Device Class
Class II
Regulation Number
866.6010
Submission Type
510(k)
Review Panel
IM
Medical Specialty
Immunology
Implant
No

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K203245NucleixBladder EpiCheck DNA extraction kit, NX899090-01C, Bladder EpiCheck test kit…May 4, 2023
K033982VysisMODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TESTJan 22, 2004
K021231MatritechNMP22 BLADDERCHEK KIT, NMP22 CONTROL KITJul 30, 2002
K013785VysisUROVYSION BLADDER CANCER RECURRENCE KITFeb 8, 2002
K011031VysisVYSIS UROVYSION BLADDER CANCER RECURRENCE KITAug 3, 2001
K974845Bard Diagnostic SciencesBTA STAT TEST PRESCRIPTION HOME USEDec 8, 1998
K971402Bard Diagnostic SciencesBARD BTA TRAK TESTApr 15, 1998
K970353PerimmuneAURA TEK FDPApr 30, 1997
K964151Bard Diagnostic SciencesBARD AND BTA TESTApr 16, 1997

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.